XKRX001795
Market cap160mUSD
Jan 03, Last price
2,320.00KRW
1D
-1.07%
1Q
-10.25%
Jan 2017
86.35%
Name
TS Corp
Chart & Performance
Profile
TS Corporation operates as a food company in South Korea. The company produces and supplies sugar and food stuff, food materials, additives, dairy products, and raw materials for bakery, mixed seasonings, and other agricultural products, as well as trades in non-ferrous metals. It also provides animal feed, including livestock feed under the Rainbow name; administrative support services, such as digital solutions for farm management; and pathology lab services comprising testing, analysis, and examination services to farmers. In addition, the company develops various nutraceuticals and premium foods to control aging and prevent adult diseases; and develops, produces, and markets two biological products, which include erythropoietin and streptokinase. It also exports its products to China, Southeast Asia, Micronesia, and internationally. The company was founded in 1956 and is headquartered in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,332,349,884 -3.32% | 1,378,075,519 9.25% | |||||||
Cost of revenue | 1,241,518,703 | 1,296,538,768 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 90,831,181 | 81,536,751 | |||||||
NOPBT Margin | 6.82% | 5.92% | |||||||
Operating Taxes | 9,656,548 | 8,870,737 | |||||||
Tax Rate | 10.63% | 10.88% | |||||||
NOPAT | 81,174,633 | 72,666,014 | |||||||
Net income | 32,573,495 27.52% | 25,543,443 26.62% | |||||||
Dividends | (11,573,935) | (10,612,141) | |||||||
Dividend yield | 4.06% | 4.65% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 148,784,025 | 208,901,700 | |||||||
Long-term debt | 249,015,723 | 232,106,823 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 4,820,603 | 4,168,084 | |||||||
Net debt | (24,075,093) | 197,578,311 | |||||||
Cash flow | |||||||||
Cash from operating activities | 40,029,747 | 11,398,287 | |||||||
CAPEX | (9,642,741) | (7,770,699) | |||||||
Cash from investing activities | 1,324,608 | 77,074,933 | |||||||
Cash from financing activities | (58,614,199) | 2,343,028 | |||||||
FCF | 64,487,910 | 117,085,585 | |||||||
Balance | |||||||||
Cash | 214,962,871 | 225,290,952 | |||||||
Long term investments | 206,911,970 | 18,139,260 | |||||||
Excess cash | 355,257,347 | 174,526,436 | |||||||
Stockholders' equity | 269,937,904 | 778,527,325 | |||||||
Invested Capital | 685,260,733 | 793,284,278 | |||||||
ROIC | 10.98% | 8.88% | |||||||
ROCE | 8.92% | 7.95% | |||||||
EV | |||||||||
Common stock shares outstanding | 89,697 | 89,697 | |||||||
Price | 3,180.00 24.95% | 2,545.00 -15.73% | |||||||
Market cap | 285,235,124 24.95% | 228,277,796 -14.32% | |||||||
EV | 264,647,303 | 429,313,385 | |||||||
EBITDA | 103,709,132 | 94,901,301 | |||||||
EV/EBITDA | 2.55 | 4.52 | |||||||
Interest | 17,077,505 | 12,935,850 | |||||||
Interest/NOPBT | 18.80% | 15.87% |